Prescription drug · NDA
Tolsura (Itraconazole) NDC 51862-462
Itraconazole 65 mg/1 · Capsule, Gelatin coated · Oral · Mayne Pharma Commercial LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51862-462-60 | 51862046260 | 60 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (51862-462-60)Marketed from Dec 11, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tolsura
- Generic name (nonproprietary)
- itraconazole
- Active ingredients
- Itraconazole — 65 mg/1
- Dosage form
- Capsule, Gelatin coated
- Route
- Oral
- Labeler
- Mayne Pharma Commercial LLCNDC labeler code 51862
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 208901
- Marketing start
- Listing expires
- Other FDA classes
- Azoles (Chemical structure)Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
- Identifiers
- Product ID 51862-462_2a3303f1-eee7-4c07-9532-e153be149369SPL ID 2a3303f1-eee7-4c07-9532-e153be149369SPL set ID 306352d1-9d5a-49ad-b72d-893b99546861RxCUI 2106642, 2106648UNII 304NUG5GF4UPC 0351862462605
- Pharmacologic class
- Azole Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451862046260followed by a unit qualifier and the quantityPackage 51862-0462-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
TOLSURA is indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised adult patients: Blastomycosis, pulmonary and extrapulmonary Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy. Specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. Therapy may be instituted before the results of the cultures and other laboratory studies are…
Excerpt only. Read the full label for complete information.
About NDC 51862-462
- What is NDC 51862-462?
- 51862-462 is the product NDC for Tolsura (itraconazole), Itraconazole 65 mg/1 capsule, gelatin coated, listed with the FDA by Mayne Pharma Commercial LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tolsura (Itraconazole).
- What is the active ingredient?
- Itraconazole.
- Who is the labeler?
- Mayne Pharma Commercial LLC, NDC labeler code 51862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tolsura?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.